.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

DILANTIN Drug Profile

« Back to Dashboard

Which patents cover Dilantin, and what substitute generic drugs are available?

Dilantin is a drug marketed by Pfizer, Parke-davis, and Parke Davis. and is included in four NDAs.

The generic ingredient in DILANTIN is phenytoin sodium. There are nineteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.

Summary for Tradename: DILANTIN

Patents:0
Applicants:3
NDAs:4
Suppliers / Packagers: see list11
Bulk Api Vendors: see list99
Clinical Trials: see list9
Patent Applications: see list5,794
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DILANTIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
DILANTIN
phenytoin
TABLET, CHEWABLE;ORAL084427-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Parke Davis
DILANTIN
phenytoin sodium
INJECTABLE;INJECTION010151-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Parke-davis
DILANTIN
phenytoin sodium
CAPSULE;ORAL084349-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Parke-davis
DILANTIN
phenytoin sodium
CAPSULE;ORAL084349-002Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Parke Davis
DILANTIN-30
phenytoin
SUSPENSION;ORAL008762-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc